Adjuvant Durvalumab for Esophageal Cancer

Clinical trial NCT02520453 · UNKNOWN

Trial details

NCT number: NCT02520453
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2016-02-01
Primary completion: 2021-06-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.